Search filters

List of works by Anita Giobbie-Hurder

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

scientific article published on 8 December 2016

A Phase I Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma

scientific article

A Retrospective Analysis of the Efficacy of Pembrolizumab in Melanoma Patients With Brain Metastasis

scientific article

A high level of estrogen-stimulated proteins selects breast cancer patients treated with adjuvant endocrine therapy with good prognosis

scientific article

A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma.

scientific article

A prospective study of radiographic manifestations in Hutchinson-Gilford progeria syndrome

scientific article

A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes

scientific article

ATIM-32. PERSONALIZED NEOANTIGEN-TARGETING VACCINE GENERATES ROBUST SYSTEMIC AND INTRATUMORAL T CELL RESPONSES IN GLIOBLASTOMA (GBM) PATIENTS

Activated HER-receptors in predicting outcome of ER-positive breast cancer patients treated with adjuvant endocrine therapy ⬇️

scientific article published on July 31, 2012

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer

scientific article

Adjuvant ovarian suppression in premenopausal breast cancer

scientific article

Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial.

scientific article published on 13 February 2017

An immunogenic personal neoantigen vaccine for patients with melanoma

scientific article

Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study.

scientific article

Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy

scientific article published on 21 December 2016

Anti-CTLA-4 based therapy elicits humoral immunity to galectin-3 in patients with metastatic melanoma.

scientific article

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

scientific article published on 20 October 2011

Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial

scientific article published in September 2010

BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells

scientific article published on 29 June 2016

Bevacizumab plus ipilimumab in patients with metastatic melanoma

scientific article

CMET-16. THE ROLE OF SURGICAL RESECTION OF MELANOMA BRAIN METASTASES IN THE IMMUNOTHERAPY ERA

CMET-16. THE ROLE OF SURGICAL RESECTION OF MELANOMA BRAIN METASTASES IN THE IMMUNOTHERAPY ERA

Challenges of guarantee-time bias

scientific article published on 08 July 2013

Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy

scientific article published on 27 October 2017

Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience

scientific article published on 02 August 2013

Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: a real-life multicenter study

scientific article published on 01 February 2019

Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome

scientific article

Clinical utility of a blood-based BRAF(V600E) mutation assay in melanoma

scientific article

Concerted potent humoral immune responses to autoantigens are associated with tumor destruction and favorable clinical outcomes without autoimmunity

scientific article

Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanoma

scientific article published in Nature

Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer

scientific article

Developing a common language for tumor response to immunotherapy: immune-related response criteria using unidimensional measurements

scientific article published on 06 June 2013

Disease progression in Hutchinson-Gilford progeria syndrome: impact on growth and development

scientific article published in October 2007

Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients

scientific article published on 6 March 2018

Early 3+3 trial dose-escalation phase I clinical trial design and suitability for immune checkpoint inhibitors

scientific article published on 20 October 2020

Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis.

scientific article

Hutchinson-Gilford progeria is a skeletal dysplasia

scientific article published on July 2011

Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin

scientific article

Immune-Related Tumor Response Dynamics in Melanoma Patients Treated with Pembrolizumab: Identifying Markers for Clinical Outcome and Treatment Decisions

scientific article

Immunity to X-linked inhibitor of apoptosis protein (XIAP) in malignant melanoma and check-point blockade

scientific article published on 18 July 2019

Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma ⬇️

scientific article published on October 28, 2011

Immunity to the vacuolar ATPase complex accessory unit ATP6S1 in patients with malignant melanoma

scientific article

Impact of Age on Outcomes with Immunotherapy for Patients with Melanoma

scientific article published on 5 May 2017

Impact of a Pre-Operative Exercise Intervention on Breast Cancer Proliferation and Gene Expression: Results from the Pre-Operative Health and Body (PreHAB) Study

scientific article published on 24 April 2019

Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors

scientific article published on 13 May 2009

Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis

scientific article

Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer ⬇️

scientific article published on May 26, 2011

L265P mutation and loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas

scientific article published on 01 February 2019

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer

scientific article

Long-Term Risk Perceptions of Women With Ductal Carcinoma In Situ ⬇️

scientific article published on April 8, 2013

MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma

scientific article published on 01 July 2018

Mechanisms of premature vascular aging in children with Hutchinson-Gilford progeria syndrome

scientific article published on 14 November 2011

Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma

scientific article

Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer

scientific article published on 21 September 2021

Molecular risk assessment of BIG 1-98 participants by expression profiling using RNA from archival tissue

scientific article

Mucosal inflammation predicts response to systemic steroids in immune checkpoint inhibitor colitis

scientific article published on 01 May 2020

Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

scientific article published on 19 December 2018

Neurologic features of Hutchinson-Gilford progeria syndrome after lonafarnib treatment

scientific article

OR19-5 The Impact Of High Dose Glucocorticoids On The Outcome Of Immune Checkpoint Inhibitor-related Thyroid Disorders And The Baseline TSH As A Predictive Biomarker

Open mesh versus laparoscopic mesh repair of inguinal hernia

scientific article

Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma

scientific article published on 21 January 2021

Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanoma

scientific article published on 11 August 2015

Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition

scientific article published on 18 February 2015

Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ

scientific article

Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancer

scientific article published on August 2010

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole

scientific article

Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy ⬇️

scientific article published on March 30, 2012

Psychosexual Functioning and Body Image Following a Diagnosis of Ductal Carcinoma In Situ ⬇️

scientific article published on July 19, 2012

Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis

scientific article published on 18 June 2020

Quality of Life in Long-Term Survivors of Metastatic Breast Cancer ⬇️

scientific article published on April 1, 2012

Quality of life and symptoms in male breast cancer survivors

scientific article published on 11 January 2013

Randomized trial of a physical activity intervention in women with metastatic breast cancer

scientific article

Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial

scientific article

Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome

scientific article

Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma

scientific article published on 01 December 2018

Risk of Bias and Heterogeneity-Reply

scientific article published on 01 June 2017

Safety of Immune Checkpoint Inhibitors in Patients With Pre-Existing Inflammatory Bowel Disease and Microscopic Colitis

scientific article published on 13 May 2020

Single Institution Experience of Ipilimumab 3 mg/kg with Sargramostim (GM-CSF) in Metastatic Melanoma

scientific article

Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis

scientific article published on 01 June 2020

Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study

scientific article

Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases

scientific article published on 01 November 2019

Tension-Free Inguinal Hernia Repair: The Design of a Trial to Compare Open and Laparoscopic Surgical Techniques ⬇️

scientific article published on May 1, 2003

The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition ⬇️

scientific article published on October 24, 2012

The Development of a Clinical Trial to Determine If Watchful Waiting is an Acceptable Alternative to Routine Herniorrhaphy for Patients with Minimal or No Hernia Symptoms ⬇️

scientific article published on May 1, 2003

The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial

scientific article

The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence

scientific article published on 03 December 2015

The impact of high-dose glucocorticoids on the outcome of immune checkpoint inhibitor-related thyroid disorders

scientific article published on 14 May 2019

The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma

scientific article

Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence.

scientific article published on 23 May 2016

Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy

scientific article published on 09 April 2020

VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma

scientific article published on 22 August 2016

Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitis

scientific article published on 22 June 2020

Watchful waiting vs repair of inguinal hernia in minimally symptomatic men: a randomized clinical trial

scientific article

Paulina is supported by:

About Paulina

Help